Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion
Withdrawn before enrolling · Phase 2
Conditions studied: Hypertension, Pulmonary, Hemolysis
In brief
The objective of this study is to assess if prolonged storage time of a packed red blood cell unit may cause pulmonary vasoconstriction after transfusion, in a susceptible population such as cardiac surgery patients. The investigators will also evaluate the potential reversal effect of Inhaled Nitric Oxide on pulmonary vasoconstriction induced by stored blood transfusions.
Key facts
- Study ID
- NCT02217683
- Run by
- Massachusetts General Hospital
- People needed
- 0
- Starts
- 2016-03-01
- Expected to finish
- 2017-04-01
- Last updated by the study team
- 2016-03-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provide written informed consent
- Elective cardiac or aortic surgery
- One or more blood transfusions scheduled for clinical reasons
- Presence of an arterial catheter and pulmonary arterial catheter
You may not qualify if…
- Emergent cardiac surgery.
- Patients requiring irradiated or washed blood transfusions.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.